About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Journal of Nuclear Medicine
›
top-articles
Journal of Nuclear Medicine
5.3
(top 5%)
impact factor
18.2K
(top 1%)
papers
603.7K
(top 1%)
citations
233
(top 1%)
h
-index
5.6
(top 5%)
extended IF
19.4K
all documents
619.3K
doc citations
332
(top 1%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Journal of Nuclear Medicine
2009
3,047
2
Partial-Volume Effect in PET Tumor Imaging
Journal of Nuclear Medicine
2007
1,227
3
A combined PET/CT scanner for clinical oncology
Journal of Nuclear Medicine
2000
1,022
4
Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution
Journal of Nuclear Medicine
1986
993
5
Recommendations on the Use of
18
F-FDG PET in Oncology
Journal of Nuclear Medicine
2008
978
6
OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine
Journal of Nuclear Medicine
2005
914
7
Evaluation of Hybrid
68
Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
Journal of Nuclear Medicine
2015
907
8
68
Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Journal of Nuclear Medicine
2019
874
9
68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT
Journal of Nuclear Medicine
2007
859
10
Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner
Journal of Nuclear Medicine
2011
828
11
Automatic quantification of ejection fraction from gated myocardial perfusion SPECT
Journal of Nuclear Medicine
1995
781
12
Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation
Journal of Nuclear Medicine
1983
768
13
Skeletal PET with
18
F-Fluoride: Applying New Technology to an Old Tracer
Journal of Nuclear Medicine
2008
746
14
225
Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
Journal of Nuclear Medicine
2016
741
15
Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography
Journal of Nuclear Medicine
1992
739
16
Standards for PET Image Acquisition and Quantitative Data Analysis
Journal of Nuclear Medicine
2009
720
17
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET
Journal of Nuclear Medicine
1995
686
18
Introduction to Radiomics
Journal of Nuclear Medicine
2020
673
19
Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data
Journal of Nuclear Medicine
2009
663
20
German Multicenter Study Investigating
177
Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
Journal of Nuclear Medicine
2017
646
21
Multicenter Standardized
18
F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
Journal of Nuclear Medicine
2008
637
22
Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis
Journal of Nuclear Medicine
1983
634
23
MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry—Standardization of Nomenclature
Journal of Nuclear Medicine
2009
633
24
Intratumor Heterogeneity Characterized by Textural Features on Baseline
18
F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer
Journal of Nuclear Medicine
2011
626
25
In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand
18
F-AV-45 (Flobetapir F 18)
Journal of Nuclear Medicine
2010
607
26
Correction for partial volume effects in PET: principle and validation
Journal of Nuclear Medicine
1998
602
27
A tabulated summary of the FDG PET literature
Journal of Nuclear Medicine
2001
594
28
The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT
Journal of Nuclear Medicine
2006
577
29
Causes and Consequences of Increased Glucose Metabolism of Cancers
Journal of Nuclear Medicine
2008
560
30
The applications of PET in clinical oncology
Journal of Nuclear Medicine
1991
542
31
Benefit of Time-of-Flight in PET: Experimental and Clinical Results
Journal of Nuclear Medicine
2008
530
32
Tumor pH and Its Measurement
Journal of Nuclear Medicine
2010
528
33
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein
Journal of Nuclear Medicine
2018
522
34
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials
Journal of Nuclear Medicine
2006
522
35
Prospective Comparison of
18
F-Fluoromethylcholine Versus
68
Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy
Journal of Nuclear Medicine
2015
516
36
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
Journal of Nuclear Medicine
2009
515
37
PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles
Journal of Nuclear Medicine
2008
507
38
SUV: standard uptake or silly useless value?
Journal of Nuclear Medicine
1995
507
39
Multimodality Molecular Imaging of Tumor Angiogenesis
Journal of Nuclear Medicine
2008
497
40
MRI-Based Attenuation Correction for PET/MRI Using Ultrashort Echo Time Sequences
Journal of Nuclear Medicine
2010
497
41
EANM/SNMMI Guideline for
18
F-FDG Use in Inflammation and Infection
Journal of Nuclear Medicine
2013
496
42
PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with
177
Lu-Labeled PSMA-617
Journal of Nuclear Medicine
2016
475
43
Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care
Journal of Nuclear Medicine
2018
474
44
68
Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
Journal of Nuclear Medicine
2019
468
45
First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses
Journal of Nuclear Medicine
2012
466
46
Ventilation-Perfusion Scintigraphy Is More Sensitive than Multidetector CTPA in Detecting Chronic Thromboembolic Pulmonary Disease as a Treatable Cause of Pulmonary Hypertension
Journal of Nuclear Medicine
2007
459
47
Molecular Imaging of Hypoxia
Journal of Nuclear Medicine
2008
455
48
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts
Journal of Nuclear Medicine
2018
453
49
First Human Imaging Studies with the EXPLORER Total-Body PET Scanner*
Journal of Nuclear Medicine
2019
453
50
Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
Journal of Nuclear Medicine
2015
451
site/software ©
exaly
; All materials licenced under
CC by-SA
.